Skip to main content
. 2011 Aug 24;11:374. doi: 10.1186/1471-2407-11-374

Table 5.

Diagnostic performance of the composite panel of three miRNAs in a testing cohort of patients with malignant SPNs and patients with benign SPNs

Sensitivity Specificity
All cases 76.32% 85.00%
Different histological types *
 AC 75.00% 85.00%
 SCC 77.78% 85.00%
Cases with different stages *
 I 75.00% 85.00%
 II 80.00% 85.00%
 III-IV 72.73% 85.00%

Abbreviations: SPNs, solitary pulmonary nodules; SCC, squamous cell carcinoma; AC, adenocarcinoma. *P > 0.05.